Article

Circulating Tumor Cell Methylation Profiles Reveal the Classification and Evolution of Non-small Cell Lung Cancer

2021-10-14

Abstract excerpt

<h4>Backgrounds: </h4>: The ability of circulating tumor cells (CTCs) to identify lung adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC) holds great promise for improving pathological diagnosis and selecting treatment in non-small cell lung cancer (NSCLC). In addition, previous studies have shown that DNA methylation exhibits cell and tissue specificity. Thus, we aimed to explore the methylation status of C...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d44f1e66-9cc7-5b87-bd1f-06b17ecfc904
DOI: 10.21203/rs.3.rs-842155/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Circulating Tumor Cell Methylation Profiles Reveal the Classification and Evolution of Non-small Cell Lung CancerDOI 10.21203/rs.3.rs-842155/v2Read

DNA methylome profiling of circulating tumor cells in lung cancer at single base-pair resolutionSemantic proximity Read

Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypesSemantic proximity Read

Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer.Semantic proximity Read

Circulating tumor cells: from new biological insights to clinical practiceSemantic proximity Read

DNA methylation-based lung adenocarcinoma subtypes can predict prognosis, recurrence, and immunotherapeutic implicationsSemantic proximity Read

A prognostic 11-DNA methylation signature for lung squamous cell carcinomaSemantic proximity Read

SCT promoter methylation is a highly discriminative biomarker for lung and many other cancersSemantic proximity Read

Development and Validation of a DNA Methylation-related Classifier of Circulating Tumour Cells to Predict Prognosis and to provide a therapeutic strategy in Lung AdenocarcinomaSemantic proximity Read

Plasma cell-free DNA methylation combined with tumor mutation detection in prognostic prediction of patients with non-small cell lung cancer (NSCLC).Semantic proximity Read

Genomic Landscape and Tumor Mutational Burden Determination of Circulating Tumor DNA in Over 5,000 Chinese Patients with Lung Cancer.Semantic proximity Read

Molecular Subtypes Based on DNA Methylation Predict Prognosis in Lung Squamous Cell CarcinomaSemantic proximity Read

A Novel Epigenetic Signature for Early Diagnosis in Lung CancerSemantic proximity Read